Publications

This section includes links to select Pharmacosmos-sponsored abstracts, posters, and publications, which cover pivotal trials and/or have appeared in peer reviewed journals and congress presentations.

Information about product(s), or investigational uses of product(s), does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Pharmacosmos does not recommend or suggest use of its product(s) in a manner inconsistent with FDA-approved labeling.

FERWON Clinical Trials

Phase 3 clinical trials performed in a total of 3050 patients with iron deficiency anemia of different etiologies that led to the FDA-approval of ferric derisomaltose. Additional analyses were performed from these data.

5 Publications

Patient Burden Studies

Studies conducted to understand and quantify the physical, emotional, social, and economic impact of specific medications, medical conditions, or disease on patients’ lives.

4 Publications

PHOSPHARE Clinical Trials

Clinical trials that evaluated the risks of hypophosphatemia with ferric derisomaltose and another intravenous iron. Additional analyses from these data and similar studies were performed.

4 Publications

Pharmacoeconomic Studies

Retrospective studies using administrative claims data to understand aspects of health care cost and utilization for patients with iron deficiency anemia.

9 Publications